Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India
India has approved Takeda's Qdenga, marking the first time a dengue vaccine has been cleared for use within the country.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
India has officially approved its first vaccine against dengue, a product developed by the Japanese drugmaker Takeda known as Qdenga. This regulatory milestone follows a clearance from the Drugs Controller General of India, or DCGI. According to reports from The Hindu and The Indian Express, the vaccine is approved for administration to individuals between the ages of 4 and 60 years. The authorization represents a significant shift in the public health landscape of India, as the country now possesses a pharmaceutical tool to combat the dengue virus specifically designed for this broad age demographic. Extensive coverage of the approval has been provided by a variety of major news outlets. Reuters focused on the role of the Japanese pharmaceutical company Takeda in bringing Qdenga to the Indian market.
NDTV has provided detailed explanations regarding the effectiveness of the vaccine, the required number of doses, and the specific eligibility criteria for patients. Meanwhile, The Times of India has highlighted the local involvement in the process, reporting that a city-based private university conducted a chemical trial for the vaccine. These outlets collectively emphasize that the DCGI clearance is the primary catalyst for the vaccine's availability. Contextual details provided by The Times of India include insights from medical professionals regarding the complexity of the disease. Doctors have explained that there are four distinct virus strains associated with dengue, which creates a significant challenge for achieving comprehensive immunity. This biological complexity explains why the arrival of an approved vaccine is viewed as a critical development.
The coverage underscores that the struggle for immunity has been a long-standing hurdle in treating and preventing the spread of the disease across the region, making the DCGI's decision to clear Qdenga a pivotal moment. Moving forward, observers will be monitoring the practical rollout of the vaccine based on the eligibility guidelines established by the DCGI. The focus remains on the specific dosing schedules and effectiveness rates as detailed by NDTV. Additionally, the outcome of the chemical trials conducted by the city-based private university, as mentioned by The Times of India, may provide further technical context for the vaccine's deployment. Future developments will likely center on how the four virus strains are addressed by Qdenga in a real-world setting as the vaccine becomes accessible to the approved 4-to-60 age group.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 114d ago.
Quick answers
Who developed the first approved dengue vaccine in India?
The vaccine, known as Qdenga, was developed by the Japanese drugmaker Takeda.
Who is eligible to receive the Qdenga vaccine in India?
The DCGI has cleared the vaccine for individuals aged 4 to 60 years.
Which regulatory body approved the vaccine?
The vaccine was approved by the Drugs Controller General of India (DCGI).
Coverage (6)
- City-based pvt varsity conducted dengue vaccine’s chemical trial The Times of India · 121d ago
- India Gets Its First Dengue Vaccine, QDENGA: Effectiveness, Doses, Eligibility Explained NDTV · 121d ago
- India approves first dengue vaccine for individuals aged 4 to 60 years The Hindu · 121d ago
- India’s first dengue vaccine approved: DCGI clears Takeda’s Qdenga for those aged 4 to 60 The Indian Express · 121d ago
- India approves dengue vaccine: Doctor explains the four virus strains and why immunity remains a major challenge The Times of India · 121d ago
- Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India Reuters · 121d ago
Topics
Related trends
All the Photos of Princess Kate and Prince William on Their Overseas Tour of Mumbai
Prince William and Princess Catherine attended the Earthshot Prize ceremony in Mumbai on Tuesday, arriving in an electric rickshaw as part of their first official overseas trip together in four years.
Crazy Taxi: World Tour ‘Welcome to India’ trailer, screenshots
SEGA reveals India as the fifth and final international location for Crazy Taxi: World Tour with a new trailer and screenshots.
UK's Prince William, Princess Kate begin India visit with street cricket
Prince William and Princess Kate have arrived in India for a three-day royal tour featuring street cricket and a subway ride.
Prince and Princess of Wales arrive in India ahead of meeting with Modi
Prince William and Princess Kate have arrived in India for a three-day visit.
Galaxy S27 Release Date: Samsung Bets Big On New 'Pro' Phone
Recent coverage details upcoming Samsung smartphone releases, specifically highlighting the Galaxy S27 Pro and Ultra camera designs.
How Trump put a key Asia-Pacific alliance ‘on life support’
President Trump will meet Quad leaders from Japan, India, and Australia in Manila next week for the first leaders' summit of his second term, amid concerns the alliance is "on life support" due to his trade wars and disengagement.